Naider Avi Z. 4
4 · Loxo Oncology, Inc. · Filed Jun 14, 2018
Insider Transaction Report
Form 4
Naider Avi Z.
Director
Transactions
- Award
Director Stock Option (right to buy)
2018-06-13+8,750→ 8,750 totalExercise: $180.98Exp: 2028-06-12→ Common Stock (8,750 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning one month after the grant date, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.